Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study.
GLP-1 受體激動劑 dulaglutide 對健康男性性功能的影響:一項隨機、雙盲、安慰劑對照的交叉研究。
EBioMedicine 2024-09-04
Maternal preconception glucose intolerance and fatty acid intake from conception to weaning: impact on offspring energy homeostasis in both male and female.
母體受孕前葡萄糖不耐症與從受孕到斷奶的脂肪酸攝取:對男性和女性後代能量穩態的影響。
Eur J Nutr 2024-09-04
Academic Detailing Compared with Group Meetings to Change Drug Prescribing for Type 2 Diabetes-A Randomized Controlled Trial.
學術詳細說明與小組會議在改變2型糖尿病藥物處方上的比較—隨機對照試驗。
J Gen Intern Med 2024-09-04
Intrapatient Changes in CT-Based Body Composition After Initiation of Semaglutide (Glucagon-Like Peptide-1 Agonist) Therapy.
Semaglutide(胰高血糖素樣肽-1 受體激動劑)治療後,患者內部 CT 基於身體組成的變化。
AJR Am J Roentgenol 2024-09-04
Lycium barbarum polysaccharide increases thermogenesis and energy metabolism through modulation of the gut microbiota to confer resistance to cold temperatures.
枸杞多醣透過調節腸道微生物群來增加熱產生和能量代謝,以增強對低溫的抵抗力。
FASEB J 2024-09-04
Frequently asked questions to the 2023 obesity medicine association position statement on compounded peptides: A call for action.
2023年肥胖醫學協會對於合成肽的立場聲明常見問題:行動的呼籲。
Obes Pillars 2024-09-04